Amneal Pharmaceuticals (AMRX) Return on Invested Capital (2018 - 2026)

Amneal Pharmaceuticals' Return on Invested Capital history runs 9 years deep, the most recent figure standing at 0.01% for Q1 2026.

• In Q1 2026, Return on Invested Capital rose 1.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.01% (up 1.0% YoY), while the FY2025 annual figure was 0.06%, up 1.0% from the prior year.
• Return on Invested Capital for Q1 2026 stood at 0.01%, up from 0.01% in the prior quarter.
• The five-year high for Return on Invested Capital was 0.02% in Q3 2023, with the low at 0.01% in Q2 2022.
• The 5-year median for Return on Invested Capital is 0.01% (2025), against an average of 0.01%.
• The sharpest annual moves came in 2022 and 2023: Return on Invested Capital declined 2 bps in 2022, then grew 3 bps in 2023.
• Amneal Pharmaceuticals' Return on Invested Capital stood at 0.0% in 2022, then jumped by 1998 bps to 0.02% in 2023, then slumped by 62 bps to 0.01% in 2024, then surged by 52 bps to 0.01% in 2025, then rose by 24 bps to 0.01% in 2026.
• Business Quant data shows AMRX's Return on Invested Capital at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.